University of Kansas Medical Center

Download Report

Transcript University of Kansas Medical Center

Atypical Presentation of
Scedosporium Pneumonia
Gabriel Johnson, DO
Leslie Spikes, MD
Department of Internal Medicine
University of Kansas Medical Center
Kansas City, KS
Introduction
 Provide a brief overview of scedosporium
epidemiology
 Present an unusual case of a life-threatening
Scedosporium infection in a patient without
typical risk factors for fungemia
 Identify diagnostic and therapeutic challenges
Scedosporium Infections in Humans
 Localized infections:
 Bronchiectatic lungs
 Mycetomas
 Disseminated infections:
 Transplant wards
 Up to 10% of cystic fibrosis patients colonized
in transplant wards
 Near drowning events
 Rarely in the immuno-competent
Cortez et. Al. Infections Caused by Scedosporium spp.
Clin Microbiol Rev. 2008 January; 21(1): 157–197.
Complication of organ transplant
 Study of 80 cases of scedosporium infection in
transplant patients at 5 academic institutions
 23 hematopoietic stem cell transplants
 57 solid organ transplants
 Disseminated infection
 2 noncontiguous organs or + blood culture
 69% of HSCT with scedosporium
 53% of SOT with scedosporium
Husein et. al. Infections due to Scedosporium in Transplant Recipients:
Clinical Characteristics. Clinical Infectious Disease 2005 Jan 1;40
Scedosporium - overview
 Ubiquitous white mold
 Tolerates aerobic and anaerobic conditions and
wide range of temperature and osmolarity
 Transmission
 Direct inoculation (mycetoma)
 Inhalation of airborne particles
Williamson et. al. Genetic Epidemiogy of Scedosporium in Patients with
Chronic Lung Disease. J Clin Microbiol. 2001 January; 39(1): 47–50.
Species
 Scedosporium apiospermum
 Typically sensitive to multi-agent antifungal
therapy
 Voriconazole associated with survival
improvement over amphotericin
 Scedosporium prolificans
 Treatment generally requires immunosuppression
reversal and surgical intervention.
Cortez et. Al. Infections Caused by Scedosporium spp.
Clin Microbiol Rev. 2008 January; 21(1): 157–197.
American Society for Microbiology: Clinical Microbiology Reviews
Infection sites 2000-2007
Lungs
Sinuses
Bone/joint
Eyes
Hands
Feet
CNS
Blood
Abdomen
59%
36%
8%
7%
4%
4%
3%
3%
2%
Cortez et. Al. Infections Caused by Scedosporium spp.
Clin Microbiol Rev. 2008 January; 21(1): 157–197.
Case Report
 A 72 year old woman presented to ER
 3 months of progressive hemoptysis
 Diffuse pulmonary nodules on recent imaging
 5 days of fever, chills, and myalgias
Past Medical History
 Pulmonary arterial hypertension




Diagnosed 2 years prior
Likely secondary to chronic pulmonary emboli
On continuous infusion intravenous treprostinil
On warfarin for chronic thromboemboli
 Breast cancer
 Right mastectomy and radiation 8 years prior
 No history of atypical or recurrent infections
Recent Medical History
 CT guided needle biopsy of pulmonary nodule
had been performed 3 weeks prior
 Histology: necrotic tissue, peribronchial fibrosis
and chronic inflammatory changes without
granulomas
 Gram stain/culture: no bacterial or fungal growth
 Cytology: no malignant cells
Social History
 Independently performs activities of daily living
 25 pack years but quit 2 years prior
 No occupational or environmental exposures
Physical Exam
T 36.7 BP 121/70 P 99 R 24 Pulse ox: 95% on room air
HEENT – Unremarkable
Chest – right sided indwelling Hickman catheter
Heart – Unremarkable
Lungs Diminished breath sounds bilaterally, no rales,
rhonchi, or wheezing
Abdomen: Unremarkable
Extremities/Skin: Unremarkable
Laboratory Data
 Fungitell: 257 (41 previously) [Normal < 40]
 Blood Culture: Scedosporium elements
The following were negative
Histoplasma Ab HIV screen
WBC
Hgb
12.9
12.3
Galactomannan
Aspergillus Ab
ANA
CMV, EBV pcr
RVP
Hep A,B,C
Plt
Neut
INR
239
80%
3.4
Scl70
Anti-dsDNA
Mycoplasma
Chlamydia
3 weeks prior
Hospital Course
 Sudden hemoptysis of 600 ml frank blood
 Resolved with reversal of anticoagulation
 Bronchoscopy with lavage performed
 Hemorrhagic fluid with negative cultures
 Repeat CT guided biopsy of left lobe nodule
 Pathologic findings unchanged and unremarkable
 Hickman catheter removed
 No fungal or bacterial growth on tip culture
Hospital Course
 Amphotericin and voriconazole initiated
 Repeat CT 2 weeks later showed progression
 Patient requested to discontinue all IV medications
and go home with home health care
 Oral voriconazole and terbinafine
 Oral sildenafil
 New 2 L oxygen requirement
Speciation and Sensitivity
 Speciation: Scedosporium Apiospermum
 Sensitivity testing:
 Amphotericin
 Caspofungin
 Micafungin
 Voriconazole
 Itraconazole
 Posaconazole
R
R
S
S
S
S
Resolution
 Patient’s hypoxia improved and she was able to
titrate off oxygen
 No recurrence of fever or hemoptysis
 She completed 6 months of antifungal therapy
with voriconazole and terbinafine
Radiographic regression
4 months later
Case Summary
 Atypical presentation of a rare fungal pathogen
 Diagnostic difficulties
 Voriconazole as preferred agent
 Questioning her risk factors
Acknowledgments
Dr. Leslie Spikes
Associate Professor of Internal Medicine
University of Kansas Medical Center
European Society for
Imunodeficiencies
Unusual infections or unusually
severe course of infections
T lymphocyte deficiency
WAS
STAT1 deficiency
Hypermorphic mutations in IκBα
X–linked lymphoproliferative syndrome
DeVries et.al. Clinical & Experimental Immunology vol. 145, iss. 2.
pages 204–214, August 2006